Carolyn Compton, Caren Mason
HealthTell said this week that Carolyn Compton and Caren Mason have joined the company's board of directors.
Compton is chief medical officer of the National Biomarkers Development Alliance at Arizona State Universitywhere she is also a professor of life sciences.
Mason was formerly CEO of Verinata Health, which was acquired by Illumina in 2013. Before that she was CEO of Quidel.